Literature DB >> 22341671

Modulation/physiology of calcium channel sub-types in neurosecretory terminals.

José R Lemos1, Sonia I Ortiz-Miranda, Adolfo E Cuadra, Cristina Velázquez-Marrero, Edward E Custer, Taimur Dad, Govindan Dayanithi.   

Abstract

The hypothalamic-neurohypophysial system (HNS) controls diuresis and parturition through the release of arginine-vasopressin (AVP) and oxytocin (OT). These neuropeptides are chiefly synthesized in hypothalamic magnocellular somata in the supraoptic and paraventricular nuclei and are released into the blood stream from terminals in the neurohypophysis. These HNS neurons develop specific electrical activity (bursts) in response to various physiological stimuli. The release of AVP and OT at the level of neurohypophysis is directly linked not only to their different burst patterns, but is also regulated by the activity of a number of voltage-dependent channels present in the HNS nerve terminals and by feedback modulators. We found that there is a different complement of voltage-gated Ca(2+) channels (VGCC) in the two types of HNS terminals: L, N, and Q in vasopressinergic terminals vs. L, N, and R in oxytocinergic terminals. These channels, however, do not have sufficiently distinct properties to explain the differences in release efficacy of the specific burst patterns. However, feedback by both opioids and ATP specifically modulate different types of VGCC and hence the amount of AVP and/or OT being released. Opioid receptors have been identified in both AVP and OT terminals. In OT terminals, μ-receptor agonists inhibit all VGCC (particularly R-type), whereas, they induce a limited block of L-, and P/Q-type channels, coupled to an unusual potentiation of the N-type Ca(2+) current in the AVP terminals. In contrast, the N-type Ca(2+) current can be inhibited by adenosine via A(1) receptors leading to the decreased release of both AVP and OT. Furthermore, ATP evokes an inactivating Ca(2+)/Na(+)-current in HNS terminals able to potentiate AVP release through the activation of P2X2, P2X3, P2X4 and P2X7 receptors. In OT terminals, however, only the latter receptor type is probably present. We conclude by proposing a model that can explain how purinergic and/or opioid feedback modulation during bursts can mediate differences in the control of neurohypophysial AVP vs. OT release. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22341671      PMCID: PMC3569038          DOI: 10.1016/j.ceca.2012.01.008

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  106 in total

1.  Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems.

Authors:  S A Deuchars; L Atkinson; R E Brooke; H Musa; C J Milligan; T F Batten; N J Buckley; S H Parson; J Deuchars
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

Review 2.  Insight into adenosine receptor function using antisense and gene-knockout approaches.

Authors:  J W Nyce
Journal:  Trends Pharmacol Sci       Date:  1999-02       Impact factor: 14.819

3.  Ca2+ syntillas, miniature Ca2+ release events in terminals of hypothalamic neurons, are increased in frequency by depolarization in the absence of Ca2+ influx.

Authors:  Valérie De Crescenzo; Ronghua ZhuGe; Cristina Velázquez-Marrero; Lawrence M Lifshitz; Edward Custer; Jeffrey Carmichael; F Anthony Lai; Richard A Tuft; Kevin E Fogarty; José R Lemos; John V Walsh
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

4.  Differential modulation of N-type calcium channels by micro-opioid receptors in oxytocinergic versus vasopressinergic neurohypophysial terminals.

Authors:  Sonia I Ortiz-Miranda; Govindan Dayanithi; Cristina Velázquez-Marrero; Edward E Custer; Steven N Treistman; José R Lemos
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

Review 5.  The functions of ATP receptors in the synaptic transmission in the hippocampus.

Authors:  K Inoue; S Koizumi; S Ueno; A Kita; M Tsuda
Journal:  Prog Brain Res       Date:  1999       Impact factor: 2.453

Review 6.  The calcium signal for transmitter secretion from presynaptic nerve terminals.

Authors:  G J Augustine; E M Adler; M P Charlton
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

7.  Do kappa opioids mimic sigma agonists as amino acid antagonists?

Authors:  C G Parsons; D Martin; R J Franklin; J L Wood; P M Headley
Journal:  Neuropharmacology       Date:  1986-02       Impact factor: 5.250

Review 8.  Molecular mechanisms of drug reinforcement and addiction.

Authors:  D W Self; E J Nestler
Journal:  Annu Rev Neurosci       Date:  1995       Impact factor: 12.449

Review 9.  Adenosine and ATP receptors in the brain.

Authors:  Geoffrey Burnstock; Bertil B Fredholm; Alexei Verkhratsky
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

10.  Excitation-secretion coupling in mammalian neurohypophysial nerve terminals.

Authors:  M C Nowycky; E P Seward; N I Chernevskaya
Journal:  Cell Mol Neurobiol       Date:  1998-02       Impact factor: 5.046

View more
  18 in total

Review 1.  Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.

Authors:  Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2015-11-06       Impact factor: 3.765

2.  Specificity in the interaction of high-voltage-activated Ca2+ channel types with Ca2+-dependent afterhyperpolarizations in magnocellular supraoptic neurons.

Authors:  Matthew K Kirchner; Robert C Foehring; Joseph Callaway; William E Armstrong
Journal:  J Neurophysiol       Date:  2018-07-18       Impact factor: 2.714

3.  Plasticity of calcium signaling cascades in human embryonic stem cell-derived neural precursors.

Authors:  Oksana Forostyak; Nataliya Romanyuk; Alexei Verkhratsky; Eva Sykova; Govindan Dayanithi
Journal:  Stem Cells Dev       Date:  2013-02-19       Impact factor: 3.272

Review 4.  Purinergic receptor types in the hypothalamic-neurohypophysial system.

Authors:  José R Lemos; Edward E Custer; Sonia Ortiz-Miranda
Journal:  J Neuroendocrinol       Date:  2018-03-07       Impact factor: 3.627

5.  Adenosine trisphosphate appears to act via different receptors in terminals versus somata of the hypothalamic neurohypophysial system.

Authors:  T K Knott; N Hussy; A E Cuadra; R H Lee; S Ortiz-Miranda; E E Custer; J R Lemos
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

6.  P2X purinergic receptor knockout mice reveal endogenous ATP modulation of both vasopressin and oxytocin release from the intact neurohypophysis.

Authors:  E E Custer; T K Knott; A E Cuadra; S Ortiz-Miranda; J R Lemos
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

Review 7.  Purinergic signaling pathways in endocrine system.

Authors:  Ivana Bjelobaba; Marija M Janjic; Stanko S Stojilkovic
Journal:  Auton Neurosci       Date:  2015-04-25       Impact factor: 3.145

Review 8.  Electrophysiological properties of identified oxytocin and vasopressin neurones.

Authors:  William E Armstrong; Robert C Foehring; Matthew K Kirchner; Celia D Sladek
Journal:  J Neuroendocrinol       Date:  2019-02-14       Impact factor: 3.627

Review 9.  Neuropeptide transmission in brain circuits.

Authors:  Anthony N van den Pol
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

Review 10.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.